Begin main content

Search

We found 6732 result(s)

Call for Feedback: Rituximab to Treat Primary Membranous Nephropathy

Published on: February 13, 2020
Result type: News

A new project on Rituximab to Treat Primary Membranous Nephropathy is now available for feedback from all interested stakeholders. Rituximab to Treat Primary Membranous Nephropathy Call for Feedback: 2020-02-13
Feedback Due By: 2020-02-28
Consultation Document: Proposed Project Scope
Product Type: Health Technology Assessment...

esketamine hydrochloride (TBC )

Last Updated: February 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: esketamine hydrochloride
Indications: Major depressive disorder (MDD), adults

  • Brand Name: TBC
  • Manufacturer: Janssen Inc.
  • Project Number: SR0621-000
  • Project Status: Active
  • Submission Type: New

Rituximab to Treat Primary Membranous Nephropathy

Last Updated: February 13, 2020
Result type: Reports

Primary membranous nephropathy (MN) is an autoimmune disease that commonly presents as nephrotic syndrome. The treatment goal of primary MN is to achieve proteinuria remission to prevent renal damage. The current guidelines recommend immunosuppressive therapies such as cyclophosphamide and calcineurin inhibitors (cyclosporine or tacrolimus) to ...

  • Project Number: HT0032-000 - HS0001-000

siponimod (Mayzent)

Last Updated: February 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: siponimod
Indications: Secondary progressive multiple sclerosis

  • Brand Name: Mayzent
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0631-000
  • Project Status: Active
  • Submission Type: New

ustekinumab (Stelara/Stelara I.V)

Last Updated: February 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ustekinumab
Indications: Ulcerative colitis

  • Brand Name: Stelara/Stelara I.V
  • Manufacturer: Janssen Inc.
  • Project Number: SR0627-000
  • Project Status: Active
  • Submission Type: New Indication

etonogestrel (TBC)

Last Updated: February 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: etonogestrel
Indications: Prevention of pregnancy

  • Brand Name: TBC
  • Manufacturer: Merck Canada Inc.
  • Project Number: SR0629-000
  • Project Status: Active
  • Submission Type: New

burosumab (Crysvita)

Last Updated: November 28, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: burosumab
Indications: Treatment of X-Linked Hypophosphatemia

  • Brand Name: Crysvita
  • Manufacturer: Kyowa Kirin Limited
  • Project Number: SR0602-000
  • Project Status: Active
  • Submission Type: New

erenumab (Aimovig)

Last Updated: February 12, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: erenumab
Indications: Migraine

  • Brand Name: Aimovig
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0578-000
  • Project Status: Active
  • Submission Type: New